Faculty of Medicine, Fayoum University, Fayoum, Egypt.
Pain Res Manag. 2021 Dec 17;2021:1723471. doi: 10.1155/2021/1723471. eCollection 2021.
Damage to the anterior cruciate ligament (ACL) is crippling and often requires an arthroscopic outpatient surgery. Nevertheless, many patients experience severe pain during the first day after ACL reconstruction (ACLR). The adductor canal block (ACB) has yielded conflicting results for post-ACLR pain relief. This research investigated the effect of a supplemental popliteal plexus block on postoperative pain outcomes compared to a sole ACB.
Following a randomized design, 60 cases scheduled for knee arthroscopy with ACLR using an ipsilateral hamstring graft were separated into two categories. Subjects in group A ( = 30) received an ACB only, while subjects in group B ( = 30) received combined ACB and popliteal plexus block (PPB).
We found significant differences between the two groups. The time of the first analgesic request (TFR) was later for the combined ACB and PPB (median 8 h) compared to the ACB only group (median 0.5 h). Morphine consumption was lower for patients who received combined ACB and PPB (median 12 mg) compared to ACB only (median 30 mg). The number of the requested doses was lower for the combined ACB and PPB group (median 3 doses) compared to the ACB only group (median 7 doses).
The addition of PPB to ACB was associated with improved analgesia and a reduced need for opioid-based sedatives following ACLR with an ipsilateral hamstring graft (https://clinicaltrials.gov/ct2/show/NCT04020133).
前交叉韧带(ACL)损伤会使人致残,通常需要进行关节镜门诊手术。然而,许多患者在 ACL 重建(ACLR)后第一天会经历严重疼痛。收肌管阻滞(ACB)在缓解 ACLR 后疼痛方面的效果存在争议。本研究旨在比较单纯 ACB 与补充腘窝神经丛阻滞(PPB)对术后疼痛结局的影响。
采用随机设计,将 60 例行同侧腘绳肌腱 ACLR 的膝关节镜手术患者分为两组。A 组(n=30)仅接受 ACB,B 组(n=30)接受 ACB 联合 PPB。
两组间存在显著差异。联合 ACB 和 PPB 的 TFR(首次请求镇痛时间)较仅接受 ACB 的组(中位数 0.5 小时)明显延迟(中位数 8 小时)。接受联合 ACB 和 PPB 的患者吗啡消耗量(中位数 12mg)低于仅接受 ACB 的患者(中位数 30mg)。联合 ACB 和 PPB 组请求的镇痛剂量(中位数 3 剂)低于仅接受 ACB 的组(中位数 7 剂)。
在同侧腘绳肌腱 ACLR 中,与单纯 ACB 相比,联合使用 PPB 可改善镇痛效果,减少阿片类药物镇静剂的需求(https://clinicaltrials.gov/ct2/show/NCT04020133)。